Analyst consensus rating

Microbot Medical Analyst Rating: none

Direct answer

Microbot Medical's consensus rating is none.

4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $5.38.
Forecast evidence checked November 16, 2026.

Get free Microbot Medical email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$0.98
Average price target
$5.38
High price target
$12.00
Low price target
$2.50
Low target gap
+155.4%
Target upside
+449.2%
High target gap
+1,126.1%
Target range width
970.7%
Consensus rating
none
Analysts
4
Evidence date
November 16, 2026
Valid through
November 23, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Microbot Medical?

Microbot Medical has a verified none consensus. The same dataset has an average price target of $5.38.

How far are Microbot Medical's low and high targets from the recorded price?

The low target implies +155.4%, while the high target implies +1,126.1%.

How many analysts are included in Microbot Medical's consensus?

The verified consensus includes 4 analysts.

How is Microbot Medical's target upside or downside calculated?

The average target of $5.38 is divided by the recorded price of $0.98, then one is subtracted to produce +449.2%. This does not guarantee a future return.

When was Microbot Medical's analyst forecast verified?

The data was verified on 2026-11-16. The dataset is valid through 2026-11-23.